Despoina Kalfakakou

Patriarchou Gregoriou E' & Neapoleos Street
Athens, ESYE31 15310, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Leveraging real-time genomic surveillance to combat infectious diseases and antimicrobial resistance in cancer patients.

Leveraging real-time genomic surveillance to combat infectious diseases and antimicrobial resistance in cancer patients.

Journal: Frontiers in public health

Published: December 08, 2025

Clonal Heterogeneity in Human Pancreatic Ductal Adenocarcinoma and Its Impact on Tumor Progression.

Clonal Heterogeneity in Human Pancreatic Ductal Adenocarcinoma and Its Impact on Tumor Progression.

Journal: bioRxiv : the preprint server for biology

Published: February 24, 2025

Genetic Testing of Breast Cancer Patients with Very Early-Onset Breast Cancer (≤30 Years) Yields a High Rate of Germline Pathogenic Variants, Mainly in the BRCA1, TP53, and BRCA2 Genes.

Genetic Testing of Breast Cancer Patients with Very Early-Onset Breast Cancer (≤30 Years) Yields a High Rate of Germline Pathogenic Variants, Mainly in the BRCA1, TP53, and BRCA2 Genes.

Journal: Cancers

Published: June 04, 2024

Extracellular matrix sensing regulates intratumoral heterogeneity of autophagic flux.

Extracellular matrix sensing regulates intratumoral heterogeneity of autophagic flux.

Journal: Cell

Published: March 31, 2024

Author Correction: Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment.

Author Correction: Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment.

Journal: Nature communications

Published: July 03, 2023

POLQ inhibition elicits an immune response in homologous recombination-deficient pancreatic adenocarcinoma via cGAS/STING signaling.

POLQ inhibition elicits an immune response in homologous recombination-deficient pancreatic adenocarcinoma via cGAS/STING signaling.

Journal: The Journal of clinical investigation

Published: October 03, 2022

MARGINAL: An Automatic Classification of Variants in BRCA1 and BRCA2 Genes Using a Machine Learning Model.

MARGINAL: An Automatic Classification of Variants in BRCA1 and BRCA2 Genes Using a Machine Learning Model.

Journal: Biomolecules

Published: August 11, 2022

Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment.

Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment.

Journal: Nature communications

Published: June 02, 2022

CHEK2 Pathogenic Variants in Greek Breast Cancer Patients: Evidence for Strong Associations with Estrogen Receptor Positivity, Overuse of Risk-Reducing Procedures and Population Founder Effects.

CHEK2 Pathogenic Variants in Greek Breast Cancer Patients: Evidence for Strong Associations with Estrogen Receptor Positivity, Overuse of Risk-Reducing Procedures and Population Founder Effects.

Journal: Cancers

Published: March 31, 2021

CanVaS: Documenting the genetic variation spectrum of Greek cancer patients.

CanVaS: Documenting the genetic variation spectrum of Greek cancer patients.

Journal: Human mutation

Published: March 15, 2021

Pathogenic Variants in Breast Cancer Susceptibility Genes in Older Women.

Pathogenic Variants in Breast Cancer Susceptibility Genes in Older Women.

Journal: JAMA

Published: July 29, 2020

Pitfalls in variant annotation for hereditary cancer diagnostics: The example of Illumina® VariantStudio®.

Pitfalls in variant annotation for hereditary cancer diagnostics: The example of Illumina® VariantStudio®.

Journal: Genomics

Published: March 23, 2020

Showing 1-12 of 19

Last Updated: 09/26/2026